Clinical trial
HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade…
NCT00144092 · Alberta Health services, Other · Completed
Key facts
| NCT number | NCT00144092 |
|---|---|
| Title | HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma |
| Official title | High Dose Chemotherapy and Autologous or Allogeneic Blood Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma |
| Lead sponsor | Alberta Health services, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Low Grade Lymphoma |
| Intervention type | Procedure |
| Interventions | stem cell source |
| Enrollment | 60 |
| Start date | May 1, 2001 |
| Completion | Jun 1, 2010 |
| First posted | Sep 5, 2005 |
| Last update posted | Nov 21, 2011 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: